Dr. Aniruddha (Anu) Hazra is an Associate Professor in the Section of Infectious Diseases and Global Health at the University of Chicago; he is Director of STI Services at the Chicago Center of HIV Elimination and director of the University's Infectious Diseases Fellowship Program. In addition to his work at UofC, he works at Howard Brown Health, the largest LGBTQ+ health provider in the country.
His clinical and research interests center on sexually transmitted infections and their impact on sexual and gender minorities as well as other vulnerable populations living on the South Side of Chicago. These interests are complemented by his clinical work in complex HIV management, PrEP care, hepatitis C management, gender affirming hormone therapy, high-resolution anoscopy, treatment of opioid use disorder, and medical education. As a former clinical ambassador of CDC's Let Stop HIV Together Campaign, he is passionate about equitable health care delivery to LGBTQ people of color.
Advancing Sexual and Gender Minority Workplace Inclusion-A Call to Action.
Advancing Sexual and Gender Minority Workplace Inclusion-A Call to Action. JAMA Netw Open. 2025 Jun 02; 8(6):e2513779.
PMID: 40465300
Perspectives of Doxycycline Postexposure Prophylaxis among Pediatric Providers.
Perspectives of Doxycycline Postexposure Prophylaxis among Pediatric Providers. Sex Transm Dis. 2025 May 23.
PMID: 40407208
Preferences for PrEP Implementation and Engagement in the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum among Patients Receiving Psychiatric Care in an Ending the HIV Epidemic Priority County.
Preferences for PrEP Implementation and Engagement in the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum among Patients Receiving Psychiatric Care in an Ending the HIV Epidemic Priority County. J Acquir Immune Defic Syndr. 2025 Apr 07.
PMID: 40192780
Resurgence of syphilis among blood donors in a single institute in Eastern India: a looming threat to public health and transfusion services.
Resurgence of syphilis among blood donors in a single institute in Eastern India: a looming threat to public health and transfusion services. Lancet Reg Health Southeast Asia. 2025 May; 36:100572.
PMID: 40235709
HIV pre-exposure prophylaxis re-initiation among men who have sex with men: a multi-center cohort study in China.
HIV pre-exposure prophylaxis re-initiation among men who have sex with men: a multi-center cohort study in China. Sex Health. 2025 03; 22.
PMID: 40096040
Promises, Pitfalls, and Progress: Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections.
Promises, Pitfalls, and Progress: Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections. Curr HIV/AIDS Rep. 2025 Feb 19; 22(1):16.
PMID: 39969650
Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic.
Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic. Open Forum Infect Dis. 2025 Mar; 12(3):ofaf094.
PMID: 40070811
Impact of Peer Referral on Pre-Exposure Prophylaxis Adherence and Persistence Among Men Who Have Sex with Men: A Cohort Study in China.
Impact of Peer Referral on Pre-Exposure Prophylaxis Adherence and Persistence Among Men Who Have Sex with Men: A Cohort Study in China. AIDS Behav. 2025 Jun; 29(6):1831-1840.
PMID: 39928073
Reply to Keyon.
Reply to Keyon. Clin Infect Dis. 2025 Feb 05; 80(1):229-230.
PMID: 38501192
Doxycycline Postexposure Prophylaxis to Prevent Bacterial Sexually Transmitted Infection.
Doxycycline Postexposure Prophylaxis to Prevent Bacterial Sexually Transmitted Infection. JAMA. 2025 Jan 21; 333(3):248-249.
PMID: 39699880